Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$546M |
| 2 |
Microsoft
MSFT
|
+$480M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$362M |
| 4 |
Meta Platforms (Facebook)
META
|
+$350M |
| 5 |
Coca-Cola
KO
|
+$266M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Robinhood
HOOD
|
+$1.04B |
| 2 |
Palantir
PLTR
|
+$800M |
| 3 |
Apple
AAPL
|
+$516M |
| 4 |
Netflix
NFLX
|
+$326M |
| 5 |
NVIDIA
NVDA
|
+$313M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.71% |
| 2 | Healthcare | 15.15% |
| 3 | Consumer Discretionary | 11.78% |
| 4 | Communication Services | 10.55% |
| 5 | Financials | 9.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3326
Elutia
ELUT
$36.7M
| $55.2K | ﹤0.01% |
61,993
+24,977
| +67% | +$46.3K |
2023 Q1
10 quarters
|
|
|
ITRM
3327
DELISTED
Iterum Therapeutics
ITRM
| $54.7K | ﹤0.01% |
81,694
-390,206
| -83% | -$306K |
2024 Q4
3 quarters
|
|
3328
Mega Matrix
MPU
$9.35M
| $54.7K | ﹤0.01% |
+2,280
| New | +$107K |
2025 Q3
0 quarters
|
|
|
HLSQ
3329
Tessera Defense and Homeland Security Inc.
HLSQ
$2.93M
| $53.8K | ﹤0.01% |
539
+406
| +305% | +$37.5K |
2025 Q2
1 quarter
|
|
|
LNAI
3330
Lunai Bioworks
LNAI
$5.35M
| $53.6K | ﹤0.01% |
+4,720
| New | +$91K |
2025 Q3
0 quarters
|
|
3331
Huadi International Group
HUDI
$10M
| $53.6K | ﹤0.01% |
+39,400
| New | +$51.1K |
2025 Q3
0 quarters
|
|
3332
Versus Systems
VS
$6.9M
| $53.5K | ﹤0.01% |
25,240
+12,140
| +93% | +$27.3K |
2025 Q2
1 quarter
|
|
3333
Matinas BioPharma
MTNB
$2.74M
| $53.4K | ﹤0.01% |
1,885
+240
| +15% | +$5.17K |
2024 Q4
3 quarters
|
|
3334
TOP Financial Group
TOP
$1.87B
| $53K | ﹤0.01% |
8,220
+1,100
| +15% | +$6.8K |
2024 Q4
3 quarters
|
|
3335
VolitionRx Ltd
VNRX
$6.61M
| $52.9K | ﹤0.01% |
3,900
+2,875
| +280% | +$38.3K |
2025 Q2
1 quarter
|
|
3336
Dawson Geophysical
DWSN
$77.9M
| $52.4K | ﹤0.01% |
+29,788
| New | +$45.3K |
2025 Q3
0 quarters
|
|
|
ADGM
3337
Adagio Medical Holdings
ADGM
$3.53M
| $52.4K | ﹤0.01% |
+27,000
| New | +$41.9K |
2025 Q3
0 quarters
|
|
|
MOGU
3338
MOGU Inc
MOGU
$17.7M
| $51.6K | ﹤0.01% |
15,057
| – | – |
2019 Q2
25 quarters
|
|
3339
Cibus
CBUS
$118M
| $51.3K | ﹤0.01% |
+39,800
| New | +$57.6K |
2025 Q3
0 quarters
|
|
3340
Nexalin Technology
NXL
$3.06M
| $51.1K | ﹤0.01% |
1,857
+312
| +20% | +$8.84K |
2025 Q2
1 quarter
|
|
3341
374Water
SCWO
$45.5M
| $50.5K | ﹤0.01% |
+17,586
| New | +$48.1K |
2025 Q3
0 quarters
|
|
|
ICG
3342
Intchains Group
ICG
$63M
| $49.8K | ﹤0.01% |
29,400
-1,300
| -4% | -$2.94K |
2025 Q2
1 quarter
|
|
3343
Boxlight
BOXL
$2.86M
| $49.8K | ﹤0.01% |
574
+47
| +9% | +$3.52K |
2021 Q1
18 quarters
|
|
|
APUS
3344
Apimeds Pharmaceuticals US
APUS
$6.93M
| $49.6K | ﹤0.01% |
+2,789
| New | +$51.7K |
2025 Q3
0 quarters
|
|
3345
Yunhong Green CTI Ltd
YHGJ
$7.18M
| $48.8K | ﹤0.01% |
10,817
-340
| -3% | -$2.18K |
2016 Q3
36 quarters
|
|
3346
Dolphin Entertainment
DLPN
$13.2M
| $48.5K | ﹤0.01% |
37,900
+4,800
| +15% | +$5.81K |
2021 Q4
15 quarters
|
|
|
ZKH
3347
ZKH Group
ZKH
$334M
| $48.1K | ﹤0.01% |
16,879
+6,779
| +67% | +$20.3K |
2025 Q1
2 quarters
|
|
3348
Volato Group
SOAR
$16.5M
| $47.4K | ﹤0.01% |
+26,800
| New | +$41K |
2025 Q3
0 quarters
|
|
3349
SKYX Platforms
SKYX
$150M
| $47.3K | ﹤0.01% |
+42,200
| New | +$47.9K |
2025 Q3
0 quarters
|
|
3350
Cryo-Cell International
CCEL
$33.1M
| $47.3K | ﹤0.01% |
+10,184
| New | +$48.3K |
2025 Q3
0 quarters
|
|
Similar funds
Renaissance Technologies's Q3 2025 Portfolio in Review
As of Q3 2025, Renaissance Technologies held 4,038 positions worth $75.8B, up 0.77% from $75.2B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Renaissance Technologies withdrew a net $5.41B in Q3 2025, closing 581 positions and reducing 1,457 holdings. Its most notable exit was GE Aerospace, an estimated $235M position sold in full.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Renaissance Technologies opened a new position in Alphabet (Google) Class C worth $419M.
- Renaissance Technologies's largest Q3 2025 buy was Alphabet (Google) Class C: 1,720,002 shares worth $419M.
- Renaissance Technologies added most to Alphabet (Google) Class A in Q3 2025, an estimated $546M increase.
- Renaissance Technologies's biggest Q3 2025 reduction was Robinhood, cutting an estimated $1.04B.
- Renaissance Technologies fully exited GE Aerospace in Q3 2025, selling an estimated $235M.
- Renaissance Technologies's ten largest holdings make up 11% of its $75.8B portfolio in Q3 2025.
- Renaissance Technologies opened 515 new positions and closed 581 in Q3 2025.
- Renaissance Technologies's portfolio value rose 0.77% quarter-over-quarter to $75.8B.
Based on Renaissance Technologies's 13F filing for Q3 2025, filed 13 Nov 2025.